CN103877091A - 用tcm278对hiv感染进行的长期治疗 - Google Patents
用tcm278对hiv感染进行的长期治疗 Download PDFInfo
- Publication number
- CN103877091A CN103877091A CN201410126123.XA CN201410126123A CN103877091A CN 103877091 A CN103877091 A CN 103877091A CN 201410126123 A CN201410126123 A CN 201410126123A CN 103877091 A CN103877091 A CN 103877091A
- Authority
- CN
- China
- Prior art keywords
- administration
- tmc278
- hiv
- preparation
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06100677 | 2006-01-20 | ||
EP06100677.1 | 2006-01-20 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800024269A Division CN101370504A (zh) | 2006-01-20 | 2007-01-19 | 用tcm278对hiv感染进行的长期治疗 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103877091A true CN103877091A (zh) | 2014-06-25 |
Family
ID=36446113
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800024269A Pending CN101370504A (zh) | 2006-01-20 | 2007-01-19 | 用tcm278对hiv感染进行的长期治疗 |
CN201410126123.XA Pending CN103877091A (zh) | 2006-01-20 | 2007-01-19 | 用tcm278对hiv感染进行的长期治疗 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800024269A Pending CN101370504A (zh) | 2006-01-20 | 2007-01-19 | 用tcm278对hiv感染进行的长期治疗 |
Country Status (28)
Country | Link |
---|---|
US (2) | US10953009B2 (zh) |
EP (1) | EP1981506B3 (zh) |
JP (2) | JP5754005B2 (zh) |
KR (2) | KR101501475B1 (zh) |
CN (2) | CN101370504A (zh) |
AP (1) | AP2936A (zh) |
AR (1) | AR059097A1 (zh) |
AU (1) | AU2007206901B2 (zh) |
BR (1) | BRPI0707179A2 (zh) |
CA (1) | CA2636436C (zh) |
CY (1) | CY1114089T1 (zh) |
DK (1) | DK1981506T6 (zh) |
EA (1) | EA014914B1 (zh) |
ES (1) | ES2414982T7 (zh) |
HK (1) | HK1125828A1 (zh) |
HR (1) | HRP20130544T4 (zh) |
IL (1) | IL192132A (zh) |
ME (1) | ME01617B (zh) |
MY (1) | MY150717A (zh) |
NZ (1) | NZ569347A (zh) |
PL (1) | PL1981506T6 (zh) |
PT (1) | PT1981506E (zh) |
RS (1) | RS52821B2 (zh) |
SG (1) | SG170073A1 (zh) |
SI (1) | SI1981506T1 (zh) |
TW (1) | TWI458483B (zh) |
UA (1) | UA96436C2 (zh) |
WO (1) | WO2007082922A2 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
TWI457136B (zh) * | 2005-04-04 | 2014-10-21 | Tibotec Pharm Ltd | Hiv-感染之預防 |
AU2016219555B2 (en) * | 2006-06-23 | 2017-08-10 | Janssen Sciences Ireland Uc | Aqueous suspensions of TMC278 |
AU2007262941B2 (en) * | 2006-06-23 | 2013-11-21 | Janssen Sciences Ireland Uc | Aqueous suspensions of TMC278 |
AU2014200819B2 (en) * | 2006-06-23 | 2016-05-26 | Janssen Sciences Ireland Uc | Aqueous suspensions of TMC278 |
CL2008000746A1 (es) | 2007-03-14 | 2008-09-22 | Tibotec Pharm Ltd | Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida. |
SG196774A1 (en) * | 2008-12-24 | 2014-02-13 | Tibotec Pharm Ltd | Implantable devices for treating hiv |
WO2011036159A2 (en) * | 2009-09-22 | 2011-03-31 | Tibotec Pharmaceuticals | Treatment and prevention of hiv infection |
AU2010338425B2 (en) | 2009-12-21 | 2015-07-23 | Janssen Sciences Ireland Uc | Degradable removable implant for the sustained release of an active compound |
RS57323B1 (sr) | 2010-01-27 | 2018-08-31 | Viiv Healthcare Co | Antivirusna terapija |
TWI577377B (zh) | 2010-09-16 | 2017-04-11 | Viiv醫療保健公司 | 醫藥組合物 |
US9266824B2 (en) | 2014-01-13 | 2016-02-23 | Warsaw Orthopedic, Inc. | Methods and compositions for making an amino acid triisocyanate |
US20190163877A1 (en) * | 2017-11-27 | 2019-05-30 | International Business Machines Corporation | Decision support for effective long-term drug therapy |
WO2022079739A1 (en) | 2020-10-14 | 2022-04-21 | Cipla Limited | Fixed dose compositions of cabotegravir and rilpivirine |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3429B1 (ar) * | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
US6568805B1 (en) * | 2001-11-26 | 2003-05-27 | Dan L. Dietz Trust | Magnetic buckle for eyeglasses |
WO2003061602A2 (en) * | 2002-01-24 | 2003-07-31 | Sangstat Medical Corporation | Combination therapy for treatment of hiv infection |
ATE508748T1 (de) | 2004-09-02 | 2011-05-15 | Janssen Pharmaceutica Nv | Salz von 4-ää4-ää4-(2-cyanoethenyl)-2,6- dimethylphenylüaminoü-2- pyrimidinylüaminoübenzonitril. |
WO2006024668A1 (en) * | 2004-09-02 | 2006-03-09 | Janssen Pharmaceutica N.V. | Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile |
TWI457136B (zh) * | 2005-04-04 | 2014-10-21 | Tibotec Pharm Ltd | Hiv-感染之預防 |
-
2007
- 2007-01-19 KR KR1020087018888A patent/KR101501475B1/ko active IP Right Grant
- 2007-01-19 US US12/161,445 patent/US10953009B2/en active Active
- 2007-01-19 TW TW096101983A patent/TWI458483B/zh active
- 2007-01-19 WO PCT/EP2007/050516 patent/WO2007082922A2/en active Application Filing
- 2007-01-19 UA UAA200809750A patent/UA96436C2/ru unknown
- 2007-01-19 EA EA200870183A patent/EA014914B1/ru unknown
- 2007-01-19 DK DK07712053.3T patent/DK1981506T6/da active
- 2007-01-19 KR KR1020147030400A patent/KR101562943B1/ko active Protection Beyond IP Right Term
- 2007-01-19 PT PT77120533T patent/PT1981506E/pt unknown
- 2007-01-19 PL PL07712053T patent/PL1981506T6/pl unknown
- 2007-01-19 SI SI200731253T patent/SI1981506T1/sl unknown
- 2007-01-19 MY MYPI20082697 patent/MY150717A/en unknown
- 2007-01-19 ME MEP-2013-66A patent/ME01617B/me unknown
- 2007-01-19 SG SG201101585-6A patent/SG170073A1/en unknown
- 2007-01-19 CN CNA2007800024269A patent/CN101370504A/zh active Pending
- 2007-01-19 CA CA2636436A patent/CA2636436C/en active Active
- 2007-01-19 ES ES07712053T patent/ES2414982T7/es active Active
- 2007-01-19 AR ARP070100247A patent/AR059097A1/es not_active Application Discontinuation
- 2007-01-19 RS RS20130258A patent/RS52821B2/sr unknown
- 2007-01-19 BR BRPI0707179-5A patent/BRPI0707179A2/pt not_active Application Discontinuation
- 2007-01-19 EP EP07712053.3A patent/EP1981506B3/en active Active
- 2007-01-19 NZ NZ569347A patent/NZ569347A/en unknown
- 2007-01-19 AU AU2007206901A patent/AU2007206901B2/en active Active
- 2007-01-19 AP AP2008004535A patent/AP2936A/xx active
- 2007-01-19 JP JP2008550764A patent/JP5754005B2/ja active Active
- 2007-01-19 CN CN201410126123.XA patent/CN103877091A/zh active Pending
-
2008
- 2008-06-12 IL IL192132A patent/IL192132A/en active IP Right Grant
-
2009
- 2009-04-21 HK HK09103670.2A patent/HK1125828A1/xx unknown
-
2013
- 2013-01-28 JP JP2013013118A patent/JP5836983B2/ja active Active
- 2013-06-14 HR HRP20130544TT patent/HRP20130544T4/hr unknown
- 2013-06-27 CY CY20131100521T patent/CY1114089T1/el unknown
-
2021
- 2021-03-01 US US17/188,850 patent/US20210177843A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103877091A (zh) | 用tcm278对hiv感染进行的长期治疗 | |
US10765674B2 (en) | Prevention of HIV-infection | |
MX2008009347A (en) | Long term treatment of hiv- infection with tcm278 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1197580 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: IRELAND JANSSEN R + D COMPANY Free format text: FORMER OWNER: JANSSEN R + D IRELAND Effective date: 20150723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: The Irish Village Applicant after: JANSSEN R&D IRELAND Address before: The Irish Village Applicant before: TIBOTEC PHARMACEUTICALS Address after: The Irish Village Applicant after: TIBOTEC PHARMACEUTICALS Address before: The Irish Village Applicant before: TIBOTEC PHARMACEUTICALS Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIBOTEC PHARM LTD. TO: JANSSEN R + D IRELAND Free format text: CORRECT: ADDRESS; FROM: Free format text: CORRECT: APPLICANT; FROM: TIBOTEC NV TO: TIBOTEC PHARM LTD. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150723 Address after: The Irish Village Applicant after: JANSSEN R&D IRELAND Address before: The Irish Village Applicant before: JANSSEN R&D IRELAND |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140625 |